Clostridium difficile infection in patients with ulcerative colitis: Investigations of risk factors and efficacy of antibiotics for steroid refractory patients - 20/04/11
, Masataka Taguri b, Masahiko Inamori c, Asami Ogura d, Eiji Miyajima d, Katsuaki Tanaka e, Shin Maeda c, Hideaki Kimura a, Reiko Kunisaki a
Corresponding author. Inflammatory Bowel Disease Center, Yokohama City University Medical Center, 4-57 Urafune, Minami-ku, Yokohama, 232-0024, Japan. Tel.:+81 45 261 5656; fax: +81 45 253 9955.Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
| pages | 6 |
| Iconographies | 1 |
| Vidéos | 0 |
| Autres | 0 |
Summary |
Background and objective |
The incidence of Clostridium difficile infection (CDI) has increased throughout the world and patients with ulcerative colitis (UC) are at a high risk for CDI. Potentially, CDI can exacerbate UC. Therefore, knowledge on the prevalence of CDI should contribute to better management of UC patients.
Methods |
The presence of toxin A antigen was defined as CDI, and the outcome of the test in patients with active UC during 2006–2009 was reviewed for identifying patients with CDI. Demographic data (disease profile, clinical response to medications and the need for colectomy) in UC patients with CDI were compared with the data from CDI free UC patients.
Results |
Fifty-five of 137 patients (40.1%) were CDI positive. Univariate and multivariate analyses revealed that CDI was not associated with any demographic factor. Intensive antibiotic therapy spared five of 17 (29.4%) steroid refractory patients with CDI from steroids. CDI was not a predictor of colectomy although this could be an outcome of efficient eradication strategy.
Conclusion |
CDI was not associated with any demographic factor or colectomy rate. However, CDI eradication therapy allowed some refractory patients to withdraw from steroids. Patients with active UC benefit from regular CDI test and eradication treatment for CDI.
Le texte complet de cet article est disponible en PDF.Plan
Vol 35 - N° 4
P. 315-320 - avril 2011 Retour au numéro
Article précédent
- The status of humoral immunity in occult HBV infection in south-eastern Iranian patients
- Mohammad Kazemi Arababadi, Ali Akbar Pourfathollah, Abdollah Jafarzadeh, Gholamhossein Hassanshahi, Ali Shamizadeh, Behzad Nasiri Ahmadabadi, Derek Kennedy
- Proximally migrated pancreatic stent successfully removed using needle-knife and forceps: Complication after precut papillotomy assisted by pancreatic stenting
- Hiroyuki Matsubayashi, Shohei Ooka, Hirokazu Kimura, Hiroaki Sawai, Naomi Kakushima, Masaki Tanaka, Michael Goggins, Hiroyuki Ono
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?